- Reports /
- Medical Tourism Market
Medical Tourism Market
Medical Tourism Market Market Research Report – Segmented By Treatment Type (Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Bariatric Surgery, Fertility Treatment, Ophthalmic Treatment, Other Treatments) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Treatment Type
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Medical Tourism Market was valued at US $22,581.90 million in 2021 and is projected to grow at 20.76% CAGR over the forecast period to reach US $70,028.28 million by 2027. Medical Tourism Market represented US $7,096.49 million opportunity over 2019-2021 and estimated to create US $47,446.38 million opportunity in 2027 over 2021.
Medical Tourism from Consainsights analyses the Medical Tourism Market in the Life Sciences industry over the forecast period to 2027.
Medical Tourism research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Medical Tourism segmentation includes Treatment Type and Geography.
Based on the Treatment Type, the Medical Tourism analysis covers Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Bariatric Surgery, Fertility Treatment, Ophthalmic Treatment, Other Treatments.
In Treatment Type segment, Cosmetic Treatment segment has highest cagr growth of 18.25%.
Based on the region, the Medical Tourism analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Medretreat, Healthbase, Apollo Hospitals, KPJ Healthcare Behard, Klinikum Medical Link, Euromedical Tours, BB Health Solutions, Cosmedic Travel and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Treatment Type
Introduction
In 2021, Cosmetic Treatment segment has the highest revenue of US $8,843.11 million and is expected to grow at CAGR of 18.25% by 2027 Cosmetic Treatment segment has highest cagr growth of 18.25%.
Cosmetic Treatment
Cosmetic Treatment segment was valued at US $6,064.11 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $27,423.20 million by 2027. Cosmetic Treatment segment represented US $2,779.00 million opportunity over 2019-2021 and estimated to create US $18,580.09 million opportunity in 2027 over 2021.
Dental Treatment
Dental Treatment segment was valued at US $3,821.55 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $17,281.87 million by 2027. Dental Treatment segment represented US $1,751.30 million opportunity over 2019-2021 and estimated to create US $11,709.01 million opportunity in 2027 over 2021.
Cardiovascular Treatment
Cardiovascular Treatment segment was valued at US $2,166.58 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $9,797.72 million by 2027. Cardiovascular Treatment segment represented US $992.88 million opportunity over 2019-2021 and estimated to create US $6,638.27 million opportunity in 2027 over 2021.
Orthopedics Treatment
Orthopedics Treatment segment was valued at US $1,453.83 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $6,574.53 million by 2027. Orthopedics Treatment segment represented US $666.25 million opportunity over 2019-2021 and estimated to create US $4,454.45 million opportunity in 2027 over 2021.
Bariatric Surgery
Bariatric Surgery segment was valued at US $737.48 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $3,335.02 million by 2027. Bariatric Surgery segment represented US $337.96 million opportunity over 2019-2021 and estimated to create US $2,259.59 million opportunity in 2027 over 2021.
Fertility Treatment
Fertility Treatment segment was valued at US $615.66 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $2,784.15 million by 2027. Fertility Treatment segment represented US $282.14 million opportunity over 2019-2021 and estimated to create US $1,886.35 million opportunity in 2027 over 2021.
Ophthalmic Treatment
Ophthalmic Treatment segment was valued at US $416.82 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $1,884.95 million by 2027. Ophthalmic Treatment segment represented US $191.02 million opportunity over 2019-2021 and estimated to create US $1,277.11 million opportunity in 2027 over 2021.
Other Treatments
Other Treatments segment was valued at US $209.37 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $946.84 million by 2027. Other Treatments segment represented US $95.95 million opportunity over 2019-2021 and estimated to create US $641.51 million opportunity in 2027 over 2021.